Back to all studies

CompletedNCT04225624

Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts

Official study title

Targeting Attentional and Cognitive Control to Enhance the Transdiagnostic Treatment of Repetitive Negative Thinking

Behavioural studyAges 18–60United StatesDepression

The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations: Boston, United StatesSee all locations and recruitment
Activities: Behavioural activities described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study information

Study start dateStarted: April 30, 2021

Recruitment status: Completed
Enrollment listed in the registry: 65
Sponsor: Massachusetts General Hospital
Sponsor type: Hospital / academic medical center
Study type: Behavioral
Intervention type: Psychotherapy / behavioral intervention
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 60 Years
Official registry ID: NCT04225624

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 60 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me